Lucy Therapeutics
Developer of proprietary mitochondrial-based small molecule therapies and diagnostic biomarkers designed for the central nervous system. The company offers genetic technologies providing unparalleled ...
Valuation
$0
Share Price
N/A
Total Raised
$42.3M
Last Round
N/A